-

$undefined

N/A

(N/A)

Contineum Therapeutics Inc. :CTNM Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need. Contineum targets biological pathways associated with specific clinical disabilities, that once modulated, can demonstrably impact the course of disease.

Location: San Diego, California, United States | Website: https://www.contineum-tx.com/ | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-17.65M

Cash

213.9M

Avg Qtr Burn

-8.337M

Short % of Float

6.58%

Insider Ownership

6.19%

Institutional Own.

82.97%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date